International Clinical Trial: An Observational Study on Gut Microbiota and Metabolomic Characteristics in Patients with Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127105) titled 'An Observational Study on Gut Microbiota and Metabolomic Characteristics in Patients with Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)' on June 24.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Zhuhai People's Hospital

Condition: Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS)

Intervention: IBD Patient Group:none Healthy control group:none

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-15

Target Sample Size: IBD Patient Group:50;Healthy control group:100;IBS Patient Group:50;

Countries of Recruit...